Clean & Clear Acne Spot Treatment: Advantage naming and the New Formula gel

The manufacturer statement identifies Advantage Acne Spot Treatment and discusses witch hazel alongside its acne and pore narrative. It does not supply a complete inactive list. That makes the name useful for discovery, but not a substitute for the full declaration of either dated label. A similarly named scrub would require its own record. Manufacturer naming record.

An exact match needs more than a shared brand and acne headline. The product-version guide explains the value of retaining the item name, format and label date together before moving to formula or outcome claims.

The November 2024 Advantage record identifies NDC 69968-0126 and a 22 mL package. Its coded dosage form is lotion. That is the field stated in this particular document, even though a shopper may think of a spot product in different terms. The record should remain a historical Advantage account rather than being renamed to match the later gel. Older label and panel. The Advantage wording links this record to a familiar commercial name, but the label’s own fields remain necessary. The dose-form code, quantity and identifier provide a more precise account than the brand family alone. They are preserved even when the newer page uses a shorter name.

The SkinCeuticals review offers another place to examine dated dosage codes. Linking the questions does not imply that the two brands share a formula, a version history or a measured result.

The July 2025 record uses NDC 69968-0804, identifies a 22 mL gel and carries New Formula and fragrance-free panel language. These are specific changes in the posted product description. They do not establish when every retailer replaced an older package, and they do not show which presentation any reader actually received. Newer gel record. Fragrance-free belongs to the newer panel in this comparison. Carrying that description back to the older fragrance-containing list would produce a false historical account. It is equally inappropriate to assume that the older base remains current because the manufacturer still uses Advantage naming.

The newer listing can be reported without creating a supply-chain story. A formula statement and fulfillment are separate matters, much as the supply-term article distinguishes a commercial description from an observed transaction.

Both labels give salicylic acid 2% as the active ingredient. Their complete inactive declarations differ. Fragrance appears in the older list, while the newer record supplies a different base alongside its fragrance-free panel. The exact lists are retained independently rather than combined into a formula that neither document actually declares. Older ingredients. Newer ingredients.

This is why the active percentage cannot carry the entire identity question. The two-percent guide separates the active field from format and base without assigning a winner on that number alone.

The older panel says 100% had clearer skin in one day. The newer panel describes a clinically proven one-day result. The examined panels do not supply the participant count, complete endpoint method or full report needed to turn those statements into one comparable study result. The changed wording deserves attribution rather than silent harmonization. Older claim. Newer claim. These statements can be transcribed accurately without treating them as equivalent definitions of clearer skin. The newer clinical wording and the older percentage each need their own supporting account before a reviewer can judge how they relate. A familiar one-day period does not supply that relationship.

A percentage without its group is especially easy to overread. The Neutrogena cream-cleanser review provides a separate reading question about package result language, without lending its product any evidence to this one.

The dated labels carry drying and flammability language, with an AHA warning field also retained. Those details are part of the product record surrounding the active and use statements. A fragrance-free panel does not authorize us to remove those cautions or give an individual assurance of comfort. Older label context. Newer label context.

This review reports the presence and role of the warning fields. It does not publish the source’s application, handling or prevention instructions. No use experience or personal compatibility assessment was performed to resolve those questions.

FDA notes that manufacturers sometimes change products or labeling, including ingredients, and that similar names can have different active ingredients. That general explanation is directly relevant to keeping these two complete records separate. Here, the active strength matches, while other fields do not. FDA label-change context. New Formula record.

The useful outcome is a clear identity boundary: manufacturer Advantage wording, an older lotion-coded label and a newer gel label. Actual stock, the reader’s package and the underlying one-day study remain outside what the examined documents establish.